• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Helix BioMedix Inc

  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Disease Focus
    • DNA Damage Response (DDR)
    • Xeroderma Pigmentosum
  • Programs
    • Pharma
    • Personal Care
  • News
    • Press Releases
    • Presentations
    • Scientific Publications
  • Investors
    • Stock Information
    • IR Updates
    • Proxy
    • Corporate Governance
  • Contact Page
You are here: Home / News / Scientific Publications

Scientific Publications

SCIENTIFIC PUBLICATIONS

PAPERS

  1. L. Zhang and T. J. Falla. Cationic antimicrobial peptides – an update. (2004) Expert Opinion in Investigational Drugs. 13: 97-106.
  2. T. J. Falla and L. Zhang. Therapeutic potential and applications of antimicrobial peptides. Mammalian antimicrobial peptides. Ed. Devine and Hancock. Cambridge University Press 2004.
  3. T. J. Falla and L. Zhang. Antimicrobial Peptides in Human Health and Disease. Ed. Richard L. Gallo. Horizon Scientific Press 2004.
  4. P.H. Lee, J.A. Rudisill, K.H. Lin, L. Zhang, S.M. Harris, T.J. Falla and R.L. Gallo. HB107, a non-bacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. (2004) Wound repair and Regeneration 12: 351-8.
  5. L. Zhang, J. Parente, S.M. Harris, D. Woods, R.E. Hancock and T.J. Falla. Antimicrobial peptide therapeutics for the cystic fibrosis lung. (2005) Antimcrob. Agents Chemother. Antimicrob Agents Chemother. 49: 2921-7.
  6. L.Zhang and T.J. Falla. Antimicrobial Peptides: therapeutic potential. Expert Opin. Pharmacother. 2006 Apr;7(6):653-63.
  7. K.Fields, T.J.Falla, K. Rodan and L.Bush. Bioactive Peptides: Signaling the future. Journal of Cosmetic Dermatology. 2009;8:8-13.
  8. L. Zhang and T.J. Falla. Host defense peptides for use as potential therapeutics. Current Opinion in Investigational Drugs. 2009; 10: 164-171.
  9. L.Zhang and T.J.Falla. Cosmeceuticals and Peptides. Clinics in Dermatology. 2009; 27: 485-494.
  10. T.J.Falla and L.Zhang. Efficacy of Heptapeptide-7 on menopausal skin. J Drugs Dermatol 2010; 9: 49-54.
  11. L.Zhang and T.J.Falla. Antibiotic Peptide Therapeutics. Methods Mol Biol 2010; 618: 303-27. Humana Press.
  12. 12. J. Falla and L. Zhang. Treatment of estrogen depleted skin. Cos. Derm. 23(10):453-458, 2010

CONFERENCE POSTERS & PRESENTATIONS

  1. L Zhang, S. Harris and T.J. Falla. HB50: A topical broad spectrum antibiotic. 103rd General Meeting, ASM, Washington DC, 2003. Abstract No. A129.
  2. T.J. Falla, L. Zhang and S. Harris. Pre-clinical development of innate immunity peptides. 4th Gordon Research Conference on Antimicrobial Peptides, Barga Italy, 2003.
  3. L. Zhang, J. Parente, S. Harris, D. Woods and T.J. Falla. Antimicrobial peptide therapeutics for cystic fibrosis. 43rd ICAAC, Chicago, IL, 2003.
  4. S. Harris. L. Zhang and T.J. Falla. HB107: A Pre-clinical therapeutic peptide. 14th Wound Healing society annual conference. May 2004 Atlanta Georgia. Abstract 141.
  5. S. Harris. L. Zhang and T.J. Falla. HB-50: A pre-clinical study of a prophylactic for wound infection. 14th Wound Healing society annual conference. May 2004 Atlanta Georgia. Abstract 111.
  6. L. Zhang, J. Parente, S. Harris and T.J. Falla. Broad spectrum antimicrobial and antiviral peptides for the prevention of sexually transmitted disease.103rd General Meeting, ASM, Washington DC, 2003. Abstract No. A058.
  7. L. Zhang, J. Parente, S. Harris and T.J. Falla. Short antifungal peptides. 44th ICAAC, Washington DC, 2004. Abstract.
  8. L.Zhang, J. Parente, S.M. Harris, M. Nair and T.J.Falla. Novel hexapeptides with potent antimicrobial activity and low toxicity. Gordon Research Conference on Antimicrobial Peptides. Ventura, California. March 2005.
  9. L. Zhang, J. Parente, S. M. Harris, A. Cole, G. F. Doncel, T. J. Falla. Antimicrobial Peptides as Potential Microbicides for Prevention of STDs. 105th General Meeting, ASM, 2005.
  10. S. Harris. L. Zhang, G. Rodeheaver, J. Parente and T.J. Falla. HB-50: A pre-clinical study of a prophylactic for wound infection. 19th American Peptide Symposium. San Diego, California. June 2005. Abstract 5869.
  11. D. Drajeske, L. Zhang, J. Parente, S. Harris and T.J. Falla. Novel Class of Anti-infective. 3rd  Anti-Infectives Partnering & Deal-Making Summit. San Diego, CA. January 2006.
  12. S. Harris, L. Zhang, J. Parente and T.J. Falla. Novel Hexapeptide Antimicrobials for the Prevention of Wound Infections.16th Annual Wound Healing Society Meeting. Scottsdale, AZ. May 17-17 2006.
  13. L.Zhang, J.Parente, S.Harris and T.J.Falla. Novel Class of Hexapeptide Anti-Infective: a Structure Activity Profile. 106th General Meeting, ASM, 2006. Abstract No.E089.
  14. T.J. Falla, S.M. Harris and L. Zhang. Novel anti-infective for the treatment and prevention of wound infections. ASM Biodefense and Emerging diseases Research Meeting. Washington DC March 1 2007. Abstract No. 184.
  15. L. Zhang, S.M. Harris and T.J. Falla. Lipohexapeptides as topical therapeutics for fungal infections. 107th General Meeting, ASM, 2007. Abstract No. A-111.
  16. S.Scheicher, L.Zhang. S.Harris and T.J.Falla. Lipohexapeptide HB1345: A novel anti-infective for acne. American Academy of Dermatology Meeting, 2008. Chicago, IL.
  17. M. Farwick et al. A novel ECM-derived tetra-peptide for efficient cosmetic anti-aging applications. 25th IFSCC Congress, October 2008. Barcelona, Spain.
  18. T.J.Falla and L.Zhang. SmartPeptides: Application and Benefits. 7th ODAC Annual Conference. January 2010 Orlando, FL.
  19. T.J. Falla and L. Zhang. Advances in the treatment of menopausal skin. Maui Derm 2010. January 2010 Maui, HI.
  20. T.Falla and L.Zhang. A New Strategy for Wound Healing Peptides. 20th Annual Meeting of the Wound Healing Society. April 2010 Orlando, FL.
  21. T.J.Falla. From Innate Immunity to Smartpeptides™. 8th Annual meeting of the Society of Dermatology SkinCare Specialists. March 2010. Miami Beach, FL.
  22. Falla and L. Zhang*. Wound healing in estrogen depleted skin. 20th NAMS Annual Meeting. October 2010. Chicago, IL.
  23. Falla* and L. Zhang. A novel Malic Mandelic Peptide Concept. Orlando dermatology. Aesthetic and Clinical Conference. Orlando, January 2011
  1. Zhang* and T. Falla. Investigation into lipolytic compounds. 2011 AAD General Meeting. New Orleans. February 2011. P1011
  2. Rodan, K. Fields, L. Bush, L. Zhang and T. Falla*. Down-regulation of cathelicidin activity for the management of rosacea-related symptoms and hyperirritable skin. 2011 AAD General Meeting. New Orleans. February 2011. P1105.
  3. Falla and L. Zhang*. Striae distensae and innate immunity. EADV Spring 2011. Czech Republic April 2011.
  4. L. Zhang* and T. Falla. The contribution of the lysine residue in the dermatological activity of GHK-Cu. 2011 AAD Summer Meeting. New York, August 2011. P400.
  5. L. Zhang*, T. Falla and R. Carmichael. Glutathione analogs with increased anti-tyrosinase activity. 2012 AAD General Meeting. San Diego, March 2012. P5546.

Primary Sidebar

Footer

COMPANY PROFILE

Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum.  Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.

 

 

 

 

Terms & Conditions | Privacy Policy

Search

 

©2023 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2025 · Executive Pro On Genesis Framework · WordPress · Log in